Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches: A Randomized Controlled Trial

NCT05679518 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT05679518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05679518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches: A Randomized Controlled Trial
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Recruiting
Start date
December 20, 2023
Completion date
June 30, 2027
Enrollment
284 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced or metastatic cancer, fear of cancer progression, metacognition-based intervention, psychooncology, supportive-expressive based intervention